'D4 t' diaporamas de présentation

Antiviral agents & Antifungal agents

Chapter 44. Antiviral agents & Antifungal agents. Yun-Bi Lu, PhD ??? Dept. of Pharmacology, School of Medicine, Zhejiang University yunbi@zju.edu.cn. 2013.12.30. Antiviral agents. Essential Characteristics of Viruses. Genome ( RNA or DNA ) packaged in a protein core

1.38k views • 59 slides

Turning the Tide on HIV/AIDS in Children and Youth Dr Chewe Luo, MD(Paed), MTropPaed, PhD Senior Programme Adviser HIV S

Turning the Tide on HIV/AIDS in Children and Youth Dr Chewe Luo, MD(Paed), MTropPaed, PhD Senior Programme Adviser HIV Section, UNICEF Programme Division New York. Outline. What does turning the tide mean? Eliminating new HIV infections in children

548 views • 36 slides

Challenges to Pediatric Antiretroviral Treatment

Challenges to Pediatric Antiretroviral Treatment. Elaine Abrams, David Hoos MTCT-Plus. What is the MTCT-Plus Initiative?. Comprehensive HIV Care and Treatment program for women and their families: women identified as HIV infected through pMTCT programs

468 views • 31 slides

Yale: the d4T story

Yale: the d4T story. 1966 : compound synthesized under a National Cancer Institute grant at the Michigan Cancer Center 1984: Yale scientists prove that d4T is potent against HIV in cell cultures 1986: Yale files for a patent 1988: Yale issues BMS exclusive worldwide license

424 views • 26 slides

ICAAC 2005

Changes in Lipids in Randomised, Open-Label Comparative Trial of Abacavir or Tenofovir DF as Replacement for a Thymidine Analogue in Persons with Lipoatrophy and Suppressed HIV RNA on HAART The RAVE Study. G Moyle 1 , C Sabin 2 , J Cartledge 3 , M Johnson 2 , E Wilkins 4 , D Churchill 5 ,

654 views • 16 slides

206 views • 11 slides

Development of NAPHA in Thailand

Development of NAPHA in Thailand . Dr Anupong Chitwarakorn Department of Disease Control Thailand. NAPHA in Thailand. Start in 2001 Shift from research based to service based Target 3,000 patients, ARV budget 6 m$ Service provider sites increased from 55 to 110 hospitals.

194 views • 9 slides

Results

A case of upregulated Cyclosporin-A catabolism in a HIV-1 + /HCV + hemophiliac after liver transplantation and Efavirenz treatment Canbay 1 , R. Gieseler 2 , K. Radecke 1 , M. Kullmer 1 , B. Ross 1 , C. Valentin-Gamazo 3 , U. Treichel 1 , and G. Gerken 1

110 views • 1 slides